FDA Inspection
Nanopharm LimitedNanopharm Limited – FDA Inspection, Sep 11, 2026
Record Details
This FDA Inspection record concerns Nanopharm Limited, with an inspection on September 11, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · c0831ddb-57c9-4162-9919-7a006589b908
Inspection Facts
- Inspection number
- 1340762
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Nanopharm Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 23, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 8, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 16, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 27, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nanopharm Limited
- FDA Inspection 1044784 - 2018-02-23
- FDA Inspection 959767 - 2016-01-08
- FDA Inspection 803567 - 2012-10-16
- FDA Inspection 607685 - 2009-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.